Toronto Dominion Bank’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,600
Closed -$24.2K – 2249
2025
Q3
$24.2K Buy
+1,600
New +$19.8K ﹤0.01% 1695

Other funds holding ROIV

Toronto Dominion Bank's ROIV Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Roivant Sciences (ROIV) in Q2 2026: 1,644 shares worth $58.2K. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in ROIV as recently as Q4 2025.

Toronto Dominion Bank first reported a position in ROIV in Q4 2025 and has held it in 2 quarters since. The position peaked at $13.7M in Q4 2025. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Toronto Dominion Bank held 1,644 shares of Roivant Sciences worth $58.2K as of Q2 2026.
  • Roivant Sciences was a new Toronto Dominion Bank position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1875 holding.
  • Toronto Dominion Bank first reported a position in Roivant Sciences in Q4 2025 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Roivant Sciences position peaked at $13.7M in Q4 2025.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.